Non-alcoholic steatohepatitis (NASH), a destructive form of non-alcoholic fatty liver disease (NAFLD), often progress to more severe disorders, such as cirrhosis and hepatocellular carcinoma. Therefore, it has been projected that NASH may even surpass the hepatitis C virus infection, becoming the major cause of liver transplantation, across the world, in the coming decade.

1. INTRODUCTION 

2. RESEARCH METHODOLOGY 

3. EXECUTIVE SUMMARY


4. MARKET DYNAMICS 

5. MARKET SEGMENTATION